Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium voltage-gated channel subfamily H member 6 (KCNH6) is a pore-forming alpha subunit of a voltage-gated inwardly rectifying potassium channel, belonging to the Eag (ether-à-go-go) related gene family. This large transmembrane protein forms tetrameric potassium-selective channels responsible for regulating ion movement across the membrane in response to changes in membrane voltage, with important roles in cellular excitability, action potential repolarization, and tissue-specific physiological functions such as neurotransmitter release, heart rate regulation, and insulin secretion. It is structurally and functionally related to other family members such as KCNH2 (hERG), which is a well-known antiarrhythmic drug target. Although KCNH6’s detailed disease roles and drug interactions are less well characterized than KCNH2, aberrations are associated with several pathologies, and safety concerns may be inferred due to the functional family’s importance in cardiac and neuronal electrophysiology[1][3][6].
Blockade/modulation of potassium flux through voltage-gated ion channel; alteration of membrane repolarization kinetics[2][3][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily H member 6 (KCNH6).